Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Charles G. Knutson, PhD

Novartis Institutes for BioMedical Research, Cambridge, MA, USA

Disclosure(s): Novartis Institutes for BioMedical Research: Employee

Poster(s):

1130 - Ensovibep antiviral activity in ambulatory patients with COVID-19 is independent of baseline anti-SARS-CoV-2 antibodies and exhibits minimal selective pressure – Results from the placebo-controlled EMPATHY trial
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET